BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRXBiotechnology
Healthcare
$7.32 +1.02%
+$0.09 today
- Market cap
- $1.88B
- Beta
- 0.56
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.89
52W Low $6.00High $10.32
Volume 3.78M
Average 4.85M
Price history
BioCryst Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+4.13%
Period high
$11.11
Period low
$6.24
Latest
$7.32
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| S-8 | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K/A | Aug 4, 2026 | Aug 4, 2026 | |
| 8-K | Jun 29, 2026 | Jun 29, 2026 |
Competitors
Who does BioCryst Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about BCRX's filings, answered from its disclosures.
What is the latest BCRX filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does BCRX have?
Intrinsic Alpha currently shows 20 recent filings for BCRX.
Continue the stock analysis
Jump to another research area for this company.